[Personalised epilepsy treatment]

Area of Science:

• Neurology
• Pediatrics
• Clinical Pharmacology

Background:

• Epilepsy is a common chronic neurological disorder in childhood, often requiring long-term medication.
• Children undergo significant physiological changes (growth, hormonal, metabolic) during treatment, impacting drug efficacy and safety.
• Current treatment selection often prioritizes seizure type over a holistic patient profile.

Purpose of the Study:

• To guide the selection of antiepileptic drugs (AEDs) with minimal side effects in pediatric epilepsy patients.
• To identify AEDs that should be avoided in children with specific comorbidities.
• To provide a framework for personalized therapeutic strategies in pediatric epilepsy.

Main Methods:

• Review of factors influencing AED selection in children.
• Analysis of drug efficacy, pharmacological properties, and adverse event profiles.
• Consideration of patient-specific variables including age, comorbidities, and lifestyle.

Main Results:

• Therapeutic decisions for pediatric epilepsy must integrate seizure characteristics with age, gender, body composition, and comorbidities.
• Pharmacological properties and adverse drug reaction profiles are critical for optimizing AED selection.
• Potential drug interactions and genetic factors warrant careful consideration in treatment planning.

Conclusions:

• A comprehensive approach, considering multiple patient-specific factors, is essential for effective and safe AED management in children.
• Personalized AED selection can minimize adverse effects and improve treatment outcomes in pediatric epilepsy.
• Avoiding specific AEDs based on comorbidities and other factors is crucial for optimizing care.